Neostigmine Methylsulfate Injection
Product Images NDC 71288-501

5 FDA label images from Meitheal Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 71288-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Neo0h 0001 01)

Figure (Neo0h 0001 01)
Chemical structure of neostigmine methylsulfate showing its molecular formula with characteristic nitrogen, sulfur, oxygen, carbon, and hydrogen atoms arranged in a specific configuration, as related to the active ingredient of the neostigmine methylsulfate injection.*
FDA Label Image

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 10 mg Per 10 mL Carton (Neostig 10mg Carton)

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 10 mg Per 10 mL Carton (Neostig 10mg Carton)
Packaging label for Neostigmine Methylsulfate Injection, USP, 10 mg per 10 mL (1 mg per mL) by Meitheal Pharmaceuticals Inc. The label states the product is for intravenous use and contains 10 x 10 mL multi-dose vials. It includes storage instructions, contents per mL, and manufacturer details, along with barcodes and a QR code for presentation purposes.*
FDA Label Image

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 10 mg Per 10 mL Vial Label (Neostig 10mg Vial)

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 10 mg Per 10 mL Vial Label (Neostig 10mg Vial)
Label for Neostigmine Methylsulfate Injection, USP 10 mg per 10 mL (1 mg per mL) for intravenous use, supplied in a 10 mL multi-dose vial. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL. The label includes active ingredient concentration details and storage instructions, noting it is sterile and nonpyrogenic.*
FDA Label Image

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 5 mg Per 10 mL Carton (Neostig 5mg Carton)

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 5 mg Per 10 mL Carton (Neostig 5mg Carton)
Packaging label for Neostigmine Methylsulfate Injection, USP, 5 mg per 10 mL (0.5 mg/mL) in multi-dose vials. The label indicates the product is for intravenous use and comes in a pack of ten 10 mL vials. The labeler is Meitheal Pharmaceuticals Inc., with storage and composition details included on the label's side panel.*
FDA Label Image

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 5 mg Per 10 mL Vial Label (Neostig 5mg Vial)

Principal Display Panel – Neostigmine Methylsulfate Injection, Usp 5 mg Per 10 mL Vial Label (Neostig 5mg Vial)
Label for neostigmine methylsulfate injection, USP, 5 mg per 10 mL (0.5 mg per mL) in a 10 mL multi-dose vial. For intravenous use. Manufactured by Meitheal Pharmaceuticals Inc. Contains details on contents, storage instructions to protect from light and temperature control, and batch information areas.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.